The Times of Israel

Israeli-developed blood test promises to take guesswork out of treating depression

Founded by two neuroscientists, NeuroKaire says its novel, AI-assisted tech uses stem cells to create a brain proxy against ...
TMCnet

NeuroKaire launches first-of-its-kind clinical test in the US, expected to dramatically reduce the 'trial and error' approach to finding the right antidepressant

The BrightKaire™, test recently received regulatory approval from the Centers for Medicare and Medicaid, marking the first ...
EurekAlert!

Toward objective diagnostics in depression: blood metabolomics for symptom profiling, suicide risk, and personalized psychiatry

Depression is a heterogeneous mental illness with substantial personal and societal burdens, yet its diagnosis still relies heavily on subjective assessments. Recent advances in blood-based ...
EurekAlert!

New meta-analysis demonstrates that access to the GeneSight test can significantly improve response and remission rates for patients with depression

SALT LAKE CITY, Sept. 3, 2025 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six ...